[Interferon alpha and pamidronate: a useful combination in the treatment of osteoporosis and systemic mastocytosis].
Brunel
V
V
Tadrist
Z
Z
Cailleres
S
S
Allegre
T
T
Blanc
A P
AP
D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D004164:Diphosphonates / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008415:Mastocytosis / Q000188:drug therapy*; D010024:Osteoporosis / Q000188:drug therapy*; D000077268:Pamidronate
D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D016898:Interferon-alpha; D000077268:Pamidronate
Interféron alpha et pamidronate: une association intéressante dans le traitement des localisations osseuses de la mastocytose systémique.